Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16
Michael Crump, Stefan Gluck, Dongsheng Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium
Sonali M Smith, Koen van Besien, Theodore Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
Ignacio Duran, Sebastien J Hotté, Holger Hirte, et al.
European Journal of Human Genetics : EJHG
|
July 18, 2013
Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, et al.
Investigational New Drugs
|
August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs
Susan M Chang, John Kuhn, Patrick Wen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2009
Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer
Carter Van Waes, Clint T Allen, Deborah Citrin, et al.
Cancer Gene Therapy
|
September 23, 2003
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer
Suzane Trudel, John Trachtenberg, Ants Toi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2008
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148
Amit M Oza, Elizabeth A Eisenhauer, Laurie Elit, et al.
Cancer Treatment and Research Communications
|
June 1, 2026
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)
Helen J MacKay, Anna V Tinker, Brad H Nelson, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer
Wells A Messersmith, Antonio Jimeno, Heather Jacene, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 21, 2007
Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16
Michael Crump, Stefan Gluck, Dongsheng Tu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium
Sonali M Smith, Koen van Besien, Theodore Karrison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2007
Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors
Ignacio Duran, Sebastien J Hotté, Holger Hirte, et al.
European Journal of Human Genetics : EJHG
|
July 18, 2013
Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care
Fiona A Miller, Robin Z Hayeems, Jessica P Bytautas, et al.
Investigational New Drugs
|
August 5, 2004
Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs
Susan M Chang, John Kuhn, Patrick Wen, et al.
International Journal of Radiation Oncology, Biology, Physics
|
November 3, 2009
Molecular and clinical responses in a pilot study of gefitinib with paclitaxel and radiation in locally advanced head-and-neck cancer
Carter Van Waes, Clint T Allen, Deborah Citrin, et al.
Cancer Gene Therapy
|
September 23, 2003
A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer
Suzane Trudel, John Trachtenberg, Ants Toi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2008
Phase II study of erlotinib in recurrent or metastatic endometrial cancer: NCIC IND-148
Amit M Oza, Elizabeth A Eisenhauer, Laurie Elit, et al.
Cancer Treatment and Research Communications
|
June 1, 2026
CRI-CCTG-0003/IND.240 an immunotherapy platform study in platinum-resistant high grade serous ovarian cancer (IPROC): Sub-studies A and B: Durvalumab (D) + mecbotamab vedotin (BA3011) or ozuriftamab vedotin (BA3021)
Helen J MacKay, Anna V Tinker, Brad H Nelson, et al.
Clinical Colorectal Cancer
|
January 7, 2011
Phase I trial of oxaliplatin, infusional 5-fluorouracil, and leucovorin (FOLFOX4) with erlotinib and bevacizumab in colorectal cancer
Wells A Messersmith, Antonio Jimeno, Heather Jacene, et al.
Page
of 8